Any feedback?
Literature summary for 3.5.1.4 extracted from
- Biotechnologisches Verfahren zur Herstellung von (S)-(+)-2,2-Dimethylcyclopropancarboxamid und (R)-(-)-2,2-Dimethylcyclopropancarbonsure (1993), Lonza AG, EP, 0502525 A1.
No PubMed abstract available
Application
| Application | Comment | Organism |
|---|---|---|
| synthesis | production of (R)-2,2-dimethylcyclopropanecarboxylic acid, which is an intermediate for the synthesis of the dehydropeptidase-inhibitor cilastatin | Delftia acidovorans |
Organism
| Organism | UniProt | Comment | Textmining |
|---|---|---|---|
| Delftia acidovorans | - |
DSM 6351 | - |
Substrates and Products (Substrate)
| Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
|---|---|---|---|---|---|---|
| (R/S)-2,2-dimethylcyclopropanecarboxamide + H2O | - |
Delftia acidovorans | (R)-2,2-dimethylcyclopropanecarboxylic acid + (S)-2,2-dimethylcyclopropanecarboxyamide | - |
? |  |
Temperature Optimum [°C]
| Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
|---|---|---|---|
| 37 | - |
- |
Delftia acidovorans |
pH Optimum
| pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
|---|---|---|---|
| 7 | - |
- |
Delftia acidovorans |
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
Legal
Curated at
Member of
